"nemocnica"

During the past decade, National Oncology Inst. ; Dept. of Haematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Oncology Inst. ; Dept. of Haematology" #1 collaborator was "Acute Leukemia French Association" with 1 trials as a collaborator and "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "National Oncology Inst. ; Dept. of Haematology" are "Non-Hodgkin's Lymphoma" (2 trials), "Anemia" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "National Oncology Inst. ; Dept. of Haematology" in a lesser frequency.

Most popular intervention types in "National Oncology Inst. ; Dept. of Haematology" are "Drug" (7 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Fludarabine" (2 trials), "Obinutuzumab" (2 trials), "Rituximab" (2 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Oncology Inst. ; Dept. of Haematology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "National Oncology Inst. ; Dept. of Haematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in National Oncology Inst. ; Dept. of Haematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Oncology Inst. ; Dept. of Haematology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".